Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
2233–2268
Headlines
2927
Sources here
18
Companies here
22
Current section United States Medical Instruments & Supplies news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Intuitive Surgical revealed a five layer AI framework for its surgical platforms. The company …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LMAT|LeMaitre Vascular Inc|Price:98.390|Chg%:+0.900

LeMaitre Vascular Inc. (LMAT) is a company that develops, manufactures, and markets devices and services for the treatment of peripheral vascular disease. The article provides an overview of the company, including its stock performance, market capitalization, P/E ratio, and executive team. It also lists …

LMAT main company
Sharemaestro market context Price below Trend Line 52 weeks -17.3% · Next-week setup positive 60.5% LMAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

POCI|Precision Optics Corporation Inc|Price:4.300|

Precision Optics Corporation Inc (POCI) shows relatively healthy fundamentals and high growth potential, with its valuation considered fairly valued. Institutional ownership is high, and analysts have issued a "Buy" rating with a target price of $8.00. The stock is currently trading sideways, suggesting potential …

POCI main company
Sharemaestro market context Price below Trend Line 52 weeks -11.4% POCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precision Optics Corporation Inc (POCI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Precision Optics Corporation Inc (POCI), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that POCI's stock is currently trading between a resistance level of 5.10 and a support level of …

POCI main company
Sharemaestro market context Price below Trend Line 52 weeks -11.4% POCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal S

Alcon Inc (ALC) has partnered with the Aravind Eye Care System to launch the Aravind Alcon Global Centre of Excellence for Vitreoretinal Surgery Training in Coimbatore, aiming to enhance specialized surgical education in ophthalmology. This initiative follows their previous collaboration on a Global Cataract …

ALC main company
Sharemaestro market context Price above Trend Line 52 weeks -8.4% ALC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nyxoah SA (NYXH) Valuation: PE, PB & Fair Value Analysis

Nyxoah SA (NYXH) has a current valuation score of 8.53, placing it 85 out of 200 in the Healthcare Equipment & Supplies industry. Its P/E ratio is -0.76, significantly below its recent high and above its recent low. Key valuation metrics like P/E, P/B, …

NYXH main company
Sharemaestro market context Price below Trend Line 52 weeks -74.8% · Next-week setup negative 43.6% NYXH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NEPH|Nephros Inc|Price:3.450|Chg%:-0.190

This article provides a comprehensive stock analysis of Nephros Inc (NEPH) based on TradingKey's stock score system. It highlights the company's healthy fundamentals, high growth potential with steady revenue growth, and relatively fair valuation. The analysis also covers institutional ownership, analyst ratings, and a …

NEPH main company
Sharemaestro market context Price above Trend Line 52 weeks +10.6% NEPH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook

WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 13.8% year on year to $872.3 million. Guidance for next quarter's revenue was …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Envista Holdings Corp (NVST) Financial Health: Profitability & Balance Sheet Analysis

Envista Holdings Corp (NVST) has a robust financial score of 8.14, ranking 40th in the Healthcare Equipment & Supplies industry. The company has shown strong financial performance with a 14.36% year-over-year revenue increase to $705.50 million and a significant 115.00% year-over-year net profit increase …

NVST main company
Sharemaestro market context Trend signal started 52 weeks +29.2% NVST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intuitive Surgical to Demonstrate Telerobotic Surgery Live at SRS

Intuitive Surgical will conduct a live telerobotic surgery demonstration at the Society of Robotic Surgery (SRS) meeting, connecting surgeons in California and Georgia. The demonstration will use the da Vinci 5 system to showcase remote collaboration and shared-control capabilities on an advanced tissue model. …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?

Intuitive Surgical (ISRG) stock has dropped 23% from its recent high due to a slowdown in U.S. robotic procedure growth, despite strong demand for its new da Vinci 5 systems and robust international growth. This presents a critical juncture for investors, prompting questions about …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India

Aravind Eye Care System and Alcon have launched a Global Centre of Excellence (CoE) for Vitreoretinal Surgery Training in Coimbatore, India. This new CoE is the second phase of their partnership, following a Global Cataract Centre of Excellence launched in 2024, aiming to address …

ALC main company
Sharemaestro market context Price above Trend Line 52 weeks -8.4% ALC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aptargroup Inc (ATR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Aptargroup Inc (ATR) has an earnings forecast score of 8.75, ranking it first in the Containers & Packaging industry. The average price target for ATR is $154.00, with analysts predominantly recommending a "Buy" trend. The company's expected revenue for the next quarter is $1.01 …

ATR main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% ATR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology stock trades lower after softer Q1 2026 revenue and cautious outlook

Align Technology's stock fell after reporting softer-than-expected Q1 2026 revenue of $1.0 billion and a 17% decline in diluted earnings per share to $1.50, missing analyst consensus. The company issued a cautious full-year 2026 outlook, projecting mid-single-digit revenue growth and continued margin pressure, despite …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Reminds Investors of Embecta Corp. (NASDAQ: EMBC) to a Securities Class Action Deadline - Contact the Firm Before August 17, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) for investors who purchased securities between November 25, 2025, and May 4, 2026. This action follows Embecta's disappointing Q2 2026 financial results and reduced fiscal 2026 revenue guidance, …

EMBC main company
Sharemaestro market context New activity signal 52 weeks -63.1% EMBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Baxter stock trades steadily as spin-off and transformation reshape earnings profile

Baxter International is undergoing a significant transition, reshaping its earnings profile through the spin-off of its Renal Care and Acute Therapies businesses into Vantive. While this restructuring led to lower revenue in fiscal 2023, the company maintained stable adjusted EPS and improved operating margins …

BAX main company
Sharemaestro market context Trend signal active 52 weeks +9.8% BAX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Baxter International Inc. Revenue Breakdown – NYSE:BAX

This article provides a detailed revenue breakdown for Baxter International Inc (BAX) by business segment and geographical region. As of April 6 (updated), the company's largest business segments are Infusion Therapies and Technologies and Care and Connectivity Solutions, while the United States accounts for …

BAX main company
Sharemaestro market context Trend signal active 52 weeks +9.8% BAX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ATR|Aptargroup Inc|Price:133.095|Chg%:-2.325

AptarGroup, Inc. is a company that designs and manufactures drug and consumer product dosing, dispensing, and protection technologies, serving pharmaceutical, beauty, food, beverage, personal care, and home care markets. The article provides an overview of the company, its financial details, and its executive team. …

ATR main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% ATR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Utah Medical Products Releases Q2 2026 Financial Results

Utah Medical Products, Inc. reported weaker second-quarter results for Q2 2026, with diluted earnings of $0.84 per share on revenue of $8.5M. This represents a decline from the prior year, attributed to headwinds across its business segments. The company, specializing in niche medical devices, …

UTMD main company
Sharemaestro market context Trend signal active 52 weeks +18.8% UTMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology Inc (ALGN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Align Technology Inc (ALGN) has an earnings forecast score of 7.79, ranking 122nd in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $175.00, with current ratings showing a consensus to "Buy" based on 19 analysts. The company's expected …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALGN|Align Technology Inc|Price:168.270|Chg%:-4.190

Align Technology Inc. (ALGN) is a global medical device company known for its Invisalign system of clear aligners and iTero intraoral scanners. The company's financials include a market cap of $11.97 billion and a P/E TTM of 28.00. Institutional holdings show 1683 institutions collectively …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

3 Promising Penny Stocks With Market Caps Over $60M

This article identifies three promising penny stocks—OraSure Technologies (OSUR), Castellum (CTM), and Protalix BioTherapeutics (PLX)—each with market caps over $60M. It highlights their financial health, recent achievements, and growth prospects, noting that while some are currently unprofitable, they exhibit strong balance sheets and strategic …

OSUR main company
Sharemaestro market context Trend signal active 52 weeks +28.0% · Next-week setup negative 40.2% OSUR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

STVN|Stevanato Group SpA|Price:19.390|Chg%:+0.020

Stevanato Group SpA (STVN) is experiencing healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Healthcare Equipment & Supplies industry. The stock is rated as a "Buy" by multiple analysts, with a target price of 25.175, indicating a significant …

STVN main company
Sharemaestro market context Trend signal active 52 weeks -6.6% STVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Solventum Corporation When-issued (SOLV) Affects Rotational Strategy Timing

This article analyzes Solventum Corporation When-issued (SOLV) using AI models to provide trading strategies. It highlights a weak near-term sentiment with a mid-channel oscillation, presenting a significant risk-reward setup. The analysis includes position, momentum, and risk-hedging strategies, along with multi-timeframe signal analysis for different …

SOLV main company
Sharemaestro market context Trend signal active 52 weeks +20.4% · Next-week setup negative 34.7% SOLV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Harvard Bioscience Inc (HBIO) Financial Health: Profitability & Balance Sheet Analysis

Harvard Bioscience Inc (HBIO) currently holds a financial score of 7.07, ranking 113 out of 200 in the Healthcare Equipment & Supplies industry, indicating a weak financial status but high operating efficiency. The company's latest quarterly revenue decreased by 4.68% year-over-year to $20.75 million, …

HBIO main company
Sharemaestro market context Trend signal active 52 weeks +36.1% · Next-week setup negative 37.0% HBIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-and-stock deal

Repligen is acquiring BioLife Solutions (BLFS) in a cash-and-stock deal valued at approximately $1.5 billion, with BioLife shareholders receiving $11.25 cash and 0.1442 Repligen shares per BioLife share. The acquisition aims to strengthen Repligen's position in the rapidly growing cell therapy market, leveraging BioLife's …

BLFS main company
Sharemaestro market context Trend signal active 52 weeks +35.4% BLFS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Femasys Inc (FEMY) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Femasys Inc (FEMY), highlighting its current market data and score on TradingKey. As of July 24, 2026, the company's valuation score is 8.97, placing it 54th in the Healthcare Equipment & Supplies industry, with a P/E ratio …

FEMY main company
Sharemaestro market context Price below Trend Line 52 weeks -79.9% · Next-week setup negative 40.5% FEMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sei Investments Co. Has $132.65 Million Stake in West Pharmaceutical Services, Inc. $WST

Sei Investments Co. has a significant stake worth $132.65 million in West Pharmaceutical Services, Inc., despite trimming its holdings by 10.6% in the first quarter. The medical instruments supplier has shown strong financial performance, beating Q2 expectations with EPS of $2.37 and revenue of …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

First Trust Advisors LP Acquires 57,931 Shares of LeMaitre Vascular, Inc. $LMAT

First Trust Advisors LP increased its stake in LeMaitre Vascular (NASDAQ:LMAT) by 6.2% during the first quarter, now holding 998,071 shares valued at $108.96 million. Other institutional investors also adjusted their positions in the company, while insiders have sold shares totaling over $5.9 million …

LMAT main company
Sharemaestro market context Price below Trend Line 52 weeks -17.3% · Next-week setup positive 60.5% LMAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CooperCompanies stock trades steadily as contact lens growth supports earnings

CooperCompanies' stock remains stable, driven by increased revenue from its CooperVision (contact lenses) and CooperSurgical (women's health) divisions. The company's fiscal 2025 results show a 7% year-over-year revenue growth to $3.1 billion, with robust operating margins and strong cash flow supporting ongoing investment and …

COO mentioned
Sharemaestro market context Price above Trend Line 52 weeks +1.3% COO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intuitive Surgical Inc (ISRG) turnover swells as weekly loss hits 15.1%

The robotic-surgery maker’s setback has pushed the 12-week return deeper into negative territory, with trend support still absent.

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context